Related references
Note: Only part of the references are listed.Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents
Miklos Fuzi et al.
FRONTIERS IN MICROBIOLOGY (2020)
Influence of antibiotic pressure on multi-drug resistant Klebsiella pneumoniae colonisation in critically ill patients
Jesus Ruiz et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2019)
Attributable mortality due to fluoroquinolone and extended-spectrum cephalosporin resistance in hospital-onset Escherichia coli and Klebsiella spp bacteremia: A matched cohort study in 129 Veterans Health Administration medical centers
Hiroyuki Suzuki et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2019)
Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union/European Economic Area, 2001 to 2018
German Penalva et al.
EUROSURVEILLANCE (2019)
Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit
Salam Abbara et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedure
Mirjana Stanic Benic et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Impact of cephalosporin restriction on incidence of infections with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an endemic setting
Kristina Nadrah et al.
JOURNAL OF CHEMOTHERAPY (2018)
Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study
Allison Muller et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2018)
Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis
Peter Collignon et al.
LANCET PLANETARY HEALTH (2018)
Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts
H Grundmann et al.
Eurosurveillance (2017)
Are Fluoroquinolones Appropriate for the Treatment of Extended-Spectrum -Lactamase-Producing Gram-Negative Bacilli?
Emily S. Wiener et al.
JOURNAL OF PHARMACY TECHNOLOGY (2016)
Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit
M. Gharbi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Effectiveness of an Antimicrobial Stewardship Approach for Urinary Catheter-Associated Asymptomatic Bacteriuria
Barbara W. Trautner et al.
JAMA INTERNAL MEDICINE (2015)
Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infection: A Serious Threat in ICUs
Yeşim Taşova
MEDICAL SCIENCE MONITOR (2015)
Implementation of an intensified antibiotic stewardship programme targeting third-generation cephalosporin and fluoroquinolone use in an emergency medicine department
Johannes P. Borde et al.
EMERGENCY MEDICINE JOURNAL (2015)
Assessment of adherence to printed guidelines for antimicrobial drug use in a university hospital
Nives Radosevic Quadranti et al.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2015)
A Multidisciplinary Intervention to Reduce Infections of ESBL-and AmpC-Producing, Gram-Negative Bacteria at a University Hospital
Jenny Dahl Knudsen et al.
PLOS ONE (2014)
Impact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative bacteria
Anastasia Antoniadou et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)
A managed multidisciplinary programme on multi-resistant Klebsiella pneumoniae in a Danish university hospital
Stig Ejdrup Andersen et al.
BMJ QUALITY & SAFETY (2013)
The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings
Mamoon A. Aldeyab et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
R. Canton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Risk Factors for Multidrug Resistance in Nosocomial Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae
So Yeon Park et al.
MICROBIAL DRUG RESISTANCE (2012)
Current Epidemiology and Growing Resistance of Gram-Negative Pathogens
David M. Livermore
KOREAN JOURNAL OF INTERNAL MEDICINE (2012)
The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey
Adalet Altunsoy et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2011)
Impact of restriction of cefepime use on the antimicrobial susceptibility of Gram-negative bacilli related to healthcare-associated infections in an orthopedic hospital
Priscila Oliveira et al.
Infection and Drug Resistance (2011)
Treatment with Fluoroquinolones or with β-Lactam-β-Lactamase Inhibitor Combinations Is a Risk Factor for Isolation of Extended-Spectrum-β-Lactamase-Producing Klebsiella Species in Hospitalized Patients
Kenneth M. Wener et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Control of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy
Jina Lee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
The effect of an antimicrobial formulary change on hospital resistance patterns
KM Empey et al.
PHARMACOTHERAPY (2002)
Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluation
M Thuong et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Share Paper
